# Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

> **NCT05059418** · NA · UNKNOWN · sponsor: **Malmö University** · enrollment: 40 (estimated)

## Conditions studied

- Burning Mouth Syndrome

## Interventions

- **DRUG:** Clonazepam 0.5 MG
- **DRUG:** Capsaicin Topical
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05059418
- **Lead sponsor:** Malmö University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05059418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05059418, "Burning Mouth Syndrome - New Diagnostic Criteria and Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05059418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*